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a  b  s  t  r  a  c  t
Although  it is  widely  acknowledged  that  most  B-cell  epitopes  are  discontinuous,  the  degree  of discon-
tinuity  is poorly  understood.  For  example,  given  that  an  antigen  having  a single  epitope  that  has  been
chopped  into  peptides  of  a speciﬁc  length,  what  is  the  likelihood  that  one  of  the peptides  will  span  all
the  residues  belonging  to  that  epitope?  Or,  alternatively,  what  is  the  largest  proportion  of  the  epitope’s
residues  that  any  peptide  is  likely  to contain?  These  and  similar  questions  are  of  direct  relevance  both  to
computational  methods  that  aim  to  predict  the  location  of  epitopes  from  sequence  (linear  B-cell  epitope
prediction  methods)  and  window-based  experimental  methods  that  aim  to  locate  epitopes  by  assessing
the  strength  of antibody  binding  to synthetic  peptides  on  a  chip.
In this  paper  we  present  an  analysis  of the  degree  of  B-cell  epitope  discontinuity,  both  in  terms  of
unctional epitope the  structural  epitopes  deﬁned  by a set  of  antigen–antibody  complexes  in  the  Protein  Data  Bank,  and
with  respect  to the  distribution  of  key  residues  that  form  functional  epitopes.  We  show  that,  taking  a
strict  deﬁnition  of  discontinuity,  all  the  epitopes  in  our  data  set  are  discontinuous.  More  signiﬁcantly,  we
provide  explicit  guidance  about  the  choice  of  peptide  length  when  using  window-based  B-cell  epitope
prediction  and mapping  techniques  based  on a detailed  analysis  of  the  likely  effectiveness  of  different
lengths.
. Introduction
.1. B-cell epitope identiﬁcation
It is widely recognized that knowledge about B-cell epitopes is
mportant for the identiﬁcation or design of therapeutic antibod-
es, and for gaining insights into vaccine effectiveness (Irving et al.,
001). Various methods may  be used to determine – with vary-
ng degrees of accuracy – the location of B-cell epitopes, ranging
rom purely computational methods to X-ray crystallography. (For
 useful survey of methods, see Ladner (2007).)
Whereas approaches such as X-ray crystallography and site-
irected mutagenesis are capable of determining the location of
-cell epitopes with a high degree of accuracy, the efﬁcacy of the
ethods we focus on here – computational methods for predicting
he location of linear B-cell epitopes and short peptide mapping
echniques – is somewhat uncertain. Nevertheless, these methods
ave an enduring appeal, as they are comparatively cheap and can
e used as the basis for high-throughput screening, properties that
ore accurate methods do not possess.
Abbreviations: ASA, accessible surface area; PDB, Protein Data Bank.
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A range of computational methods have been developed for pre-
dicting which of an antigen’s residues are likely to form part of
an epitope (El-Manzalawy and Honavar, 2010). In the absence of
useful structural information about the antigen, predictions must
be made using the primary amino-acid sequence alone. Typically a
ﬁxed-length proﬁle is generated from a set of known examples and
applied to a given antigen using a sliding window.
Such methods are primarily suited to ﬁnd linear B-cell epitopes,
i.e. epitopes that consist of a single more-or-less continuous seg-
ment from the primary sequence. But this begs the questions: How
strict does the deﬁnition of “continuous” have to be? And what
proportion of epitopes meet these requirements in practice?
Short peptide mapping involves the synthesis of relatively short
overlapping peptides from the antigen of interest and measuring
the extent to which they bind to a given antibody. The peptide may
be in linear conformation, or constrained in some way to mimic, to
some degree, the 3-dimensional conformation of that peptide in its
natural (in vivo) structural context (Timmerman et al., 2009). Given
an antigen of interest, it is up to the researcher to decide how to split
it into individual peptides. In practice, experimentalists typically
choose a ﬁxed window size (peptide length) and shift that window
by a ﬁxed amount along the full length of the antigen sequence
(maintaining a consistent degree of overlap). However, the window
size and degree of shift can vary signiﬁcantly between different
experiments. For example, Geysen et al. (1984) chose a window
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verlap of ﬁve), whereas Behan et al. (1998) used a window of size
7 shifted by ﬁve residues (hence an overlap of 12). Peptides of
p to 32 residues were used by Timmerman et al. (2007),  but such
arge window sizes are exceptional.
Note that in this paper we deliberately exclude from consider-
tion variations on these peptide-mapping approaches that model
iscontinuous epitopes by combining non-adjacent segments from
 protein sequence. To be effective, such approaches generally
equire signiﬁcant prior knowledge about the location of epitope
esidues – see, for example, the analysis of CD20 antibodies in
iederfellner et al. (2011).
Before considering whether these epitope prediction and small
eptide mapping approaches have inherent limitations, it is essen-
ial to consider what is known about the properties of B-cell
pitopes.
.2. Properties of B-cell epitopes
There are various ways of deﬁning what an “epitope” is (see
adner, 2007), but probably the most widely used deﬁnition is that
f a structural epitope. A structural epitope consists of the set of
he antigen’s amino-acid residues that are in direct contact with
esidues belonging to an antibody (the paratope).
Several fundamental properties of structural epitopes have been
uantiﬁed in an analysis of 53 antigen–antibody complexes from
he Protein Data Bank (PDB) (Berman et al., 2000) undertaken by
ubinstein et al. (2008).  For example, the study concluded that
pproximately 75% of epitopes consist of 15–25 residues with a sur-
ace area of 600–1000 A˚2. They also partially quantiﬁed the degree
o which B-cell epitopes are discontinuous. No epitopes in their
ata set were found to be strictly linear, i.e. composed of a single,
ontinuous segment of the antigen’s amino-acid sequence having
ll residues in direct physical contact with one or more antibody
esidues. Using a less strict criterion that allowed up to three non-
ontact residues to occur within a segment, the authors found that
ost epitopes consist between one and ﬁve segments, each con-
aining one to six residues.
Whereas the deﬁnition of a structural epitope is widely used and
asy to grasp, it is not necessarily the most relevant for the purpose
f epitope mapping. On the one hand, some non-contact residues
ave been shown to induce conformational changes that affect
ntigen–antibody binding (Parry et al., 1990); on the other hand,
t is widely recognized that, in general, only a subset of contact
esidues within an epitope make a signiﬁcant contribution to the
lobal binding energy (Novotny, 1991). These energetically impor-
ant residues – which typically number between three and ﬁve,
nd which can be determined experimentally using site-directed
utagenesis (Benjamin and Perdue, 1996) – are commonly known
s hot spot residues and collectively form a so-called functional
pitope.
The properties of protein–protein interfaces in general have
een widely characterized in the literature; a small number of
ot-spot residues account for most of the binding energy (Bogan
nd Thorn, 1998) and are grouped in one or a few “hot regions”
owards the centre of the interface (Keskin et al., 2004). However,
hereas some authors assume there is nothing special about B-cell
pitopes – indeed, the term epitope is sometimes used loosely to
efer to any protein interface (see, for example, Ma et al., 2001) –
his assumption may  not be justiﬁed, as there are important dif-
erences between the binding characteristics of antigen–antibody
omplexes and those of other classes of complex. For example,
ackson found that serine protease–inhibitor complexes involve
ackbone interactions, whereas side-chain interactions dominate
n antigen–antibody complexes (Jackson, 1999).
All things considered, we should expect antigen–antibody inter-
aces to be a special case. Whereas other protein–protein interfacesr Immunology 51 (2012) 304– 309 305
will typically have evolved cooperatively (with both partners mak-
ing a complementary contribution), in antigen–antibody interfaces
the antigen is either passive or actively evolves to resist the for-
mation of the complex. Whereas other protein–protein interfaces
are likely to be mature (established over signiﬁcant periods of
time), antigen–antibody interfaces are often transients (witness, for
example, the short-lived effectiveness of most antibodies against
the evolving inﬂuenza A virus (Wilson and Cox, 1990)).
1.3. The limitations of window-based methods
Some of the current limitations of window-based computa-
tional prediction methods and peptide mapping techniques have
already been discussed elsewhere. Blythe and Flower (2005)
demonstrated that simple sequence proﬁles based on a sin-
gle propensity scale are little better than random at predicting
the location of linear epitopes. For short peptide mapping tech-
niques, the likely conformational differences between a given
peptide and the corresponding region from the intact protein have
been widely acknowledged (Van Regenmortel, 2006; Chen et al.,
2009).
But arguably there remains an even more fundamental ques-
tion: for methods that utilize relatively small windows onto the
primary amino-acid sequence, how likely is it that a segment will
be found that spans a signiﬁcant number of epitope residues? This
is one of the questions we  address in this paper. More generally, we
seek to extend the analysis already carried out by Rubinstein et al.
(2008) into the properties of structural epitopes by quantifying the
degree to which B-cell epitopes – both structural and functional –
are discontinuous.
2. Methods
2.1. Protein data set
A dataset of X-ray crystallographic antigen–antibody structures
was  constructed based on an initial list derived from the Summary
of Antibody Crystal Structures (SACS) database (Allcorn and Martin,
2002). Various criteria were imposed to ﬁlter out inappropriate
structures, notably those with missing data or of low quality. Hence
structures were removed that did not have:
• A resolution of ≤3 A˚.
• An antibody component comprising at least part of both heavy
and light chains.
• An antigen component containing at least 30 amino-acid
residues.
• And a complete structural epitope (i.e. no missing information
relating to the antigen’s epitopic residues).
We also excluded structures where the epitope includes residues
from multiple chains of the antigen. Such epitopes are relatively
uncommon (accounting for only 2.6% of those selected according
to the preceding criteria), although they are potentially important
in speciﬁc contexts; for example, epitopes that span the HA1 and
HA2 domains in inﬂuenza A haemagglutinin are at the centre of
research seeking to identify the targets for vaccines with long-
term effectiveness (Ekiert et al., 2009; Corti et al., 2011). However,
such epitopes are hard or impossible targets for the window-based
methods we  are concerned with here, which consider only contin-
uous peptides, and including them would have over-complicated
our analyses.
Given the need to automate the selection of appropriate struc-
tures for our data set, various heuristics were implemented (based























































all the contact residues belonging to that epitope. In Fig. 2, we
have plotted the lengths of the minimal spanning peptides in a
histogram.06 G.N. Sivalingam, A.J. Shepherd / Mo
nable to reliably extract information in a relatively straightfor-
ard manner. For example, we excluded any structure for which we
ere unable to identify the antibody chains using simple keywords
such as “heavy”, “H”, “light”, “L” and “IG”).
Having applied these criteria, we ended up with a data set con-
isting of 150 antigen–antibody complexes.
.2. Structural epitope data set
Within our set of complexes, an individual residue forming part
f the antigen was deemed to be part of the structural epitope pro-
ided its accessible surface area (ASA) increases when the antibody
s removed from the complex. ASA was calculated by applying the
hrake–Rupley algorithm (Shrake and Rupley, 1973).
This approach is broadly similar to that adopted by a number of
uthors (Ponomarenko and Bourne, 2007; Rubinstein et al., 2008),
ut different approaches are possible. For example, a distance cut-
ff of 6 A˚ is used to deﬁne epitopes for the Epitome database
Schlessinger et al., 2006), whereas Sobolev et al. (1999) exclude
rom consideration putative interactions involving atom pairings
hat are electrostatically unfavourable (e.g. between an aliphatic
arbon and a carbonyl oxygen). In a preliminary comparison of the
ffect of using different criteria for deﬁning epitope residues on
 set of six structures (results not shown), the criteria we have
dopted differed by only 1.5% from those used in the study by
ubinstein et al. (2008),  which represents the closest comparable
tudy to our own.
.3. Functional epitope data sets
Although there are some examples of functional epitopes for
hich the precise residues are known, the number is comparatively
mall. Here we analyse a small set of known functional epitopes,
erived from the data set in Duquesnoy (2006),  but our main anal-
sis focuses on two sets of simulated functional epitopes derived
rom our structural data set. These two sets represent the two
xtremes of how the residues of a functional epitope might be dis-
ributed with respect to the corresponding structural epitope. In
he ﬁrst set, all functional residues are assumed to be clustered in a
ingle patch located centrally within the corresponding structural
pitope; in the second set, the functional residues are assumed to
e randomly distributed across the structural epitope as a whole.
With both these data sets, functional epitopes having three and
ve residues were assessed. For the random set, results for a given
unctional epitope having a set number of residues were calculated
s follows. All unique combinations of that number of residues
ithin the set of residues forming the corresponding structural
pitope were calculated. In the case where there were fewer than
00 such combinations, all were selected; when there were more
han 100 combinations, 100 were selected from the full set at ran-
om. Analysis was carried out on the combined set of randomized
ariants from all structures.
. Results
.1. Structural epitope segmentation
As in the earlier data set of Rubinstein et al. (2008),  none of the
pitopes in our structural data set are strictly linear, i.e. with no gaps
ermitted between the epitopic residues in direct contact with the
ntibody. However, this is an excessively stringent requirement for
any purposes. For example, for small peptide mapping methodso be successful, it is probably necessary that a signiﬁcant percent-
ge of key epitopic residues occur within a peptide that maps onto
hat epitope, but that does not mean that a continuous stretch of
esidues within the peptide need to map  to contact residues.r Immunology 51 (2012) 304– 309
Here we  adopt a similar approach to that used by Rubinstein
et al. (2008) by progressively relaxing the deﬁnition of a continu-
ous segment (Fig. 1). In Fig. 1(A), a strict deﬁnition of continuous
segment is applied, i.e. a gap of a single non-epitope residue is sufﬁ-
cient for the sequence to be split into two segments. In Fig. 1(B), one
or more gaps of up to three consecutive non-epitope residues are
tolerated, but not a gap of four or more non-epitope residues. And
in Fig. 1(C) one or more gaps of up to ﬁve consecutive non-epitope
residues are tolerated.
One striking feature of these results is that, even when we allow
generous gaps of up to ﬁve non-epitope residues to occur within
a single segment (Fig. 1(C)), a substantial majority (85%) of epi-
topes have multiple segments. With a less generous gap of up to
three non-epitope residues within a segment, 88% of structures
have multiple segments.
3.2. Preliminary analysis of functional epitopes
In Table 1 we summarize the characteristics of six experi-
mentally determined functional epitopes presented in Duquesnoy
(2006) that are associated with known structural epitopes.1
Duquesnoy points out that the functional epitopes associated with
three structures (PDB ID: 1VFB, 3HFL, 1JRH) consist of a single patch
located centrally within the corresponding structural epitope,
whereas the functional epitopes associated with the remaining
three structures (PDB ID: 1HFM, 1FBI, 1WEJ) comprise two distinct
patches.
In terms of the questions we address in this paper, what we are
interested in is the number of residues that occur within a func-
tional epitope and how they are distributed with respect to the
underlying primary sequence. In this respect, the results in Table 1
are instructive, in spite of the small sample size. On the one hand,
the number of residues making up a given functional epitope does
not appear to be highly correlated with the length of the short-
est peptide that spans all the residues belonging to that functional
epitope; hence the functional epitope with the shortest spanning
peptide has the largest number of functional residues (PDB ID:
1JRH). On the other hand, there does appear to be a signiﬁcant rela-
tionship between the length of the shortest spanning peptide and
the way functional residues are distributed in terms of the forma-
tion of contiguous patches in three-dimensional space; hence the
average length of the minimum spanning peptide for functional
epitopes consisting of a single patch (12 residues) is much shorter
than that for functional epitopes in which the residues are clustered
in more than one patch (66.7 residues).
In the absence of a public database of functional epitopes, we
have chosen to derive two sets of simulated functional epitopes
– each containing simulated epitopes with three and ﬁve key
functional residues – that map  onto known structural epitopes
in contrasting ways: either clustered in a single centrally located
patch, or distributed randomly (see Section 2.3).
3.3. Minimal spanning peptide
For any single-chain structural or functional epitope, there is
a corresponding minimal peptide (consisting of a continuous sub-
sequence of the full amino-acid sequence for that chain) that spans1 A seventh structure from Duquesnoy (2006) (PDB ID: 1DQJ) has been omitted
on  the grounds that its functional epitope shares two out of three epitopic residues
with one of our chosen structures (PDB ID: 1FBI).
G.N. Sivalingam, A.J. Shepherd / Molecular Immunology 51 (2012) 304– 309 307
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Cig. 1. The segmentation of structural epitopes using different deﬁnitions of a conti
equential non-epitope residues are tolerated within a single segment. (C) Gaps of 
Fig. 2(A) is sobering for those hoping to capture all the residues
n a structural epitope within a single synthetic (or computation-
lly modelled) peptide of even moderate length, as the number of
pitopes for which all epitopic residues are captured with a peptide
f length 20 is less than 10%. When the peptide length is raised to
0 – which is signiﬁcantly longer than all the small peptide map-
ing experiments we are aware of – the percentage rises to only
8%.
The same analyses performed for our artiﬁcial sets of functional
pitopes give results that are more promising for window-based
ethods. In the worst-case scenario (Fig. 2(B)), with functional epi-
opes consisting of ﬁve residues that are randomly distributed with
espect to the corresponding structural epitope, 21% are captured
y peptides of length 20 and 40% by peptides of length 40. A more
able 1
omparison of structural and functional characteristics of six epitopes.
PDB code Structural epitopea
Number of residues Span 
1VFB 23 117 
3HFL  21 44 
1HFM 24 95 
1FBI  26 89 
1WEJ  18 102 
1JRH 17 53 
a All numbers calculated by the authors.
b Span calculated by the authors, other numbers taken from Duquesnoy (2006). segment. (A) No gaps are tolerated within a single segment. (B) Gaps of up to three
ve sequential non-epitope residues are tolerated within a single segment.
realistic opportunity for window-based methods to capture all the
desired information arises when the residues of functional epitopes
form a single central patch. With ﬁve such residues (Fig. 2(C)), pep-
tides of length 20 capture 47% of the epitopes, and peptides of
length 40 capture 69%; with only three such residues (Fig. 2(E))
– the best-case scenario for window-based methods – peptides of
length 20 capture 67% of the epitopes, and peptides of length 40
capture 80%.
Even in the best-case scenario, these results are rather discour-
aging for advocates of window-based epitope detection methods.
Commonly used peptide lengths of 7–15 residues will fail to capture
all the key functional residues in about 50% of cases – even when the
functional epitopes comprise only three residues that are adjacent
to each other in three-dimensional space. But there remains one
Functional epitopeb


























tig. 2. Histograms (with bins of size 10) of the lengths of the minimal spanning p
omprising 5 randomly located residues. (C) Functional epitopes comprising 5 cen
E)  Functional epitopes comprising 3 centrally located residues.
edeeming possibility: that, in practice, it is necessary to capture
ome – but not all – of the key functional residues.
.4. Epitope coverage given windows of different sizes
For window-based methods, whether computational or exper-
mental, a key question is: how much of an epitope am I likely to
ncompass, on average, for a given window size/peptide length?
he answer to this question is given in Fig. 3 for structural epi-
opes, functional epitopes with ﬁve randomly distributed residues,
nd functional epitopes with ﬁve residues that form a single, central
atch.These results show that windows of the size typically used in
mall peptide experiments (7–15 residues) capture roughly 35–55%
f structural epitope residues, 50–65% of residues in functional
ig. 3. Graphs showing the average percentage of epitope residues (y-axis) capture
y  peptides of different lengths (x-axis). The score is averaged across the best span-
ing peptides for all epitopes in the given data set, where the best spanning peptide
of a given length) for a single epitope is the one that spans the greatest number of
hat  epitope’s residues (compared to other peptides of the same length).es for the epitopes in our dataset. (A) Structural epitopes. (B) Functional epitopes
located residues. (D) Functional epitopes comprising 3 randomly located residues.
epitopes when the residues are randomly distributed, and 70–80%
of residues when the functional residues form a single patch.
4. Discussion
It is easy to understand the enduring appeal of window-based
techniques – both computational and experimental – for identify-
ing the location of B-cell epitopes. Experimental techniques of high
accuracy, such as X-ray crystallography and site-directed mutage-
nesis, are much more time consuming and expensive. But doubts
remain about the true efﬁcacy of window-based methods, and there
is a persistent risk of reporting bias; in other words, a risk that
the apparent successes of such methods will be reported in the
literature, whereas their failures will not.
In this paper we  have sought to shed light upon the intrinsic
limitations of a range of computational and experimental window-
based techniques given their reliance on linear peptides of modest
length. We have concluded our analysis on a relatively positive
note (see Section 3.4). In the most favourable scenario where, for
a method to successfully locate a B-cell epitope, it needs to only
detect three or four residues from a single patch comprising a small
set of key binding residues, our results give signiﬁcant grounds for
optimism; in most cases, there exists a peptide of modest length
(of 15 residues or less) that will span at least that number of
residues.
However, not all epitopes have a single-patch of key func-
tional residues; our results suggest that epitopes having functional
residues that are more widely distributed will often be missed by
methods that rely on short linear peptides. Moreover, it may tran-
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pitopes is reﬂected in a degree of bias towards epitopes that are
etectable by such approaches within the PDB itself.
We should also end with a further note of caution. In order for
n epitope to be successfully detected using any of the window-
ased techniques considered in this paper, it is probably necessary
or there to exist, within the full protein sequence, a compara-
ively short peptide spanning most of that epitope’s key functional
esidues. However, the existence of such a peptide is not necessarily
ufﬁcient. For short peptide mapping techniques, the conformation
f such a peptide in three-dimensional space is likely to play a vital
ole in their success or failure, but this is a topic that lies outside
he scope of this paper.
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Glossary
Discontinuous epitope: An epitope that is not a linear epitope, i.e. an epitope that
consists of multiple, distinct segments from the primary amino-acid sequence.
Functional epitope: The subset of residues belonging to an epitope that accounts for
most of the binding energy in the antigen–antibody complex. Typically there
are  between three and ﬁve such residues.
Linear epitope: Strictly speaking, an epitope consisting of a single continuous
segment from the primary amino-acid sequence. However, less stringent deﬁ-
nitions that allow the continuity of the segment to be broken by a small number
of  non-epitope residues are widely used.
Short peptide mapping technique: A technique for locating the epitopes of a given
antigen that involves synthesizing a series of short overlapping peptides from
that antigen’s primary sequence and measuring which ones bind to an antibody.
Structural epitope: The set of amino-acid residues belonging to an antigen that is in
direct contact with a corresponding set of residues belonging to an antibody.
